Ontology highlight
ABSTRACT: Objective
17β-hydroxysteroid dehydrogenase isoform 12 (HSD17B12) overexpression is associated with poor clinical outcome in invasive ductal carcinoma of the breast. Here, we evaluated HSD17B12 overexpression and its activity in ovarian carcinoma (OvCa) to determine its role in the growth and progression of this tumor.Methods
Immunohistochemical analysis of HSD17B12 expression was performed in 100 tissue samples of untreated OvCa and was correlated with clinicopathologic characteristics and patient outcome. In A2780 OvCa cell line expressing HSD17B12, siRNA knockdown of the enzyme was performed, and its effects on tumor cell growth and Annexin V binding were determined.Results
HSD17B12 expression was detected in all tumor samples, but the staining intensity was varia
SUBMITTER: Szajnik M
PROVIDER: S-EPMC3607433 | biostudies-literature | 2012 Dec
REPOSITORIES: biostudies-literature